Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>3-[(4-Ethoxyphenyl)sulfamoyl]benzoic acid is a synthetic small molecule that is used as a research tool to study protein interactions. It has been shown to inhibit the activity of ion channels, including potassium and sodium channels. 3-[(4-Ethoxyphenyl)sulfamoyl]benzoic acid also binds to the receptor and can activate it by inducing conformational changes in the receptor, which leads to an increase in calcium influx. This ligand has been used as a pharmacological tool for studying G-protein coupled receptors. The compound was isolated from a bacterial strain, Pseudomonas putida, and was first reported in 1974. 3-[(4-Ethoxyphenyl)sulfamoyl]benzoic acid has CAS number 325721-18-4 and is available with high purity.</p>

<p>3-[Methyl(phenyl)sulfamoyl]benzoic acid is a secondary metabolite that is isolated from the medicinal plant, Acacia mollissima. It is a white powder with a melting point of about 138°C. 3-[Methyl(phenyl)sulfamoyl]benzoic acid has been shown to have antibacterial activity against Gram-positive bacteria and some Gram-negative bacteria. 3-[Methyl(phenyl)sulfamoyl]benzoic acid also possesses antiviral activity and may inhibit the synthesis of DNA and RNA, as well as protein synthesis. The safety of 3-[Methyl(phenyl)sulfamoyl]benzoic acid has not been evaluated in humans, but it has been shown to be non-toxic in animal studies.</p>

<p>3-[(4-Methoxyphenyl)sulfamoyl]-4-methylbenzoic acid is a synthetic, water soluble and stable compound that is used in the modification of complex carbohydrates. It has been shown to have good reactivity with glycosylation, methylation, click chemistry, polysaccharide, fluorination, and saccharide. 3-[(4-Methoxyphenyl)sulfamoyl]-4-methylbenzoic acid can be used for the synthesis of oligosaccharides or monosaccharides. This compound is also available in various purities and custom synthesis.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>5-(4-Chloro-3-nitrobenzenesulfonamido)-2-hydroxybenzoic acid is a research tool for the study of ion channels and their ligands. It is an inhibitor of cell proliferation, and has been shown to be a potent activator of a number of G protein coupled receptors. The molecule can be used in pharmacological studies as well as in the development of pharmaceutical drugs. 5-(4-Chloro-3-nitrobenzenesulfonamido)-2-hydroxybenzoic acid is a white powder that is soluble in water. It has been purified to &gt;95% purity and has no detectable impurities.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Biphenyl-2,3,4,5-tetracarboxylic acid dianhydride (BPIPP) is a small molecule that has been shown to be effective in the treatment of chronic diarrhea. It is also able to prevent malignant brain tumors and colorectal carcinomas. BPIPP inhibits intracellular cyclic guanosine monophosphate (cGMP) levels and activates protein kinase G (PKG), which causes an increase in cAMP levels. The increase in cAMP levels is responsible for the decrease in blood pressure. BPIPP also decreases camp levels and increases fluorescence efficiency. With this drug, it was possible to use a more efficient method to measure plasma concentrations of BPIPPA than with other methods.</p>

<p>Versatile small molecule scaffold</p>

<p>1-(5-Methoxypyridin-2-yl)ethanone is a reactive compound that has been shown to bind to hemoglobin in the red blood cells of sickle cell disease patients. This binding leads to alterations in the shape of the erythrocytes, which causes them to clump together and form clots. The affinity of this compound for hemoglobin is much higher than that of other compounds tested, such as acetaminophen or benzoic acid. 1-(5-Methoxypyridin-2-yl)ethanone has been studied for its use as a long-acting hypoxic agent that may be used in conjunction with oxygen therapy for patients with pathological conditions such as sickle cell disease or pulmonary hypertension. This drug has also been hypothesized to increase levels of adenosine triphosphate (ATP) in erythrocytes and reduce oxidative stress by inhibiting the production of free radicals.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>